Aerogen Booth A10 at ERS 2006 will feature Dr. Alexandru Steriade sharing expert perspectives on aerosol delivery and inhaled therapy.

Public source

Publisher name

Public post

How can we maximise the therapeutic potential of inhaled treatments in obstructive lung disease? At European Respiratory Society (ERS) 2006, join Dr. Alexandru Steriade…

Log in to read the full post

Company

Aerogen

We're devoted to improving the lives of vulnerable patients worldwide through superior aerosol drug delivery.

Industry
Medical Equipment Manufacturing
Location
Lower Dangan, IE
Company size
501–1,000 employees

About Aerogen

*Galway Chamber Company of the Year 2025* *Galway Chamber Community and Social Impact Award 2025* Aerogen improves the lives of vulnerable patients worldwide through superior aerosol drug delivery – ultimately transforming respiratory care. Dedicated to scientific excellence, Aerogen innovates based on what’s best for the patient and care team and is focused on: - Bringing peace of mind to patients and loved ones by safely and rapidly delivering more medication to the lungs, increasing speed of recovery. - Helping care providers more effectively treat patients, while also empowering them to focus on strategic tasks and reducing their risk of exposure to patient-generated infectious aerosols. - Assisting health systems to improve patient satisfaction and outcomes, reduce admissions, increase hospital discharges and decrease length of stay by more safely and effectively getting medications to patients. - Helping to drive the next generation of effective and safer aerosol medication delivery for the treatment of many of the world’s most difficult health issues, in partnership with pharmaceutical companies.

See more

Latest activity

2 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.